輔助生殖技術 (ART) 市場 - 按類型、最終用戶 - 全球預測

Assisted Reproductive Technology (ART) Market - By Type, End-User - Global Forecast

出版日期: 2024年05月09日 | 出版商:

Global Market Insights Inc. | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於受壓力、年齡和環境變化等生活方式因素影響的不孕率上升，輔助生殖技術市場規模預計在 2024 年至 2032 年間將實現 6.9% 的複合年成長率。體外受精 IVF 和子宮內人工授精 IUI 等技術使個人和夫婦克服生育挑戰。

輔助生殖技術 ART 方法被廣泛開發，以提高成功率並最大限度地降低患者的風險。此外，新技術和改進方案的整合正在擴大輔助生殖技術的能力，為不孕症患者帶來希望，進一步強化其作為生殖保健重要選擇的作用。根據世界衛生組織的報告，全球約 17.5% 的成年人患有不孕症。這凸顯了多種技術的迫切必要性，以擴大獲得負擔得起的高品質生育護理的機會。

ART 產業分為類型、最終用戶/提供者和地區。

由於迫切需要幫助個人和夫婦透過解決生育挑戰來實現為人父母的夢想，因此該產品類型細分市場的市場佔有率預計到 2032 年將大幅成長。 ART結合體外受精IVF、卵胞漿內單一精子顯微注射ICSI等先進技術，提供更個人化、更有效的解決方案，並將基因篩檢和創新治療融為一體。隨著研究人員不斷發現提高成功率的新方法，ART 產品變得更加容易取得和精緻。

就最終用戶/提供者而言，醫院領域的輔助生殖技術市場預計將在 2024 年至 2032 年期間產生可觀的收入。這受到了專家不斷成長的需求的青睞，他們利用基因篩檢和冷凍保存等技術來提高成功率和患者治療效果。醫院正在透過整合人工智慧和基因編輯等尖端創新來推進 ART，以提高診斷準確性和治療效果，從而使生育治療更加高效、侵入性更小。

受可支配收入增加以及用於提高這些服務品質和可及性的醫療保健投資激增的推動，到 2032 年，亞太地區輔助生殖技術行業規模可能會顯著成長。政府和私營部門正在向醫療基礎設施投入資源，以確保擁有最先進的設施和先進技術，從而促進區域市場的成長。

產業生態系統分析
產業影響力
- 成長動力
  - 整個人群的不孕症盛行率不斷上升
  - 人口結構轉向接受輔助生殖技術 (ART)
  - 輔助生殖科技的科技進步
  - 人們對輔助生殖技術的認知不斷提高
- 產業陷阱與挑戰
  - 手續費用高
  - 新興國家的社會障礙和缺乏先進的基礎設施
成長潛力分析
技術景觀
監管環境
定價分析，2021 - 2032
- 按地區分類的程序定價分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
產品
- 媒體
- 導管
- 針
- 玻璃化冷凍裝置
- 孵化器
- 其他產品
程式
- 按類型
  - 新鮮捐贈者
  - 新鮮非捐贈者
  - 冷凍供體
  - 冷凍非捐贈者
- 依技術
  - 體外受精 (IVF)
    - IVF 胞漿內單一精子注射 (ICSI)
    - 無 ICSI 的 IVF
  - 人工授精 - 子宮腔內授精 (AI-IUI)

第 6 章：市場估計與預測：按最終用戶/提供者分類，2021 - 2032 年

主要趨勢
醫院
生育診所
其他最終用戶/提供者

第 7 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 埃及
- 中東和非洲其他地區

第 8 章：公司簡介

Esco Micro Pte. Ltd
Gynotec
Hamilton Thorne Ltd.
Indira IVF Hospital Private Limited
Ivy Fertility
Kitazato Corporation
Laboratoire CCD
Liverpool Partners Group
Merck KGaA
MISTRAL FERTILITY CLINICS S.L.
NidaCon International AB
Sumitomo Mitsui Financial Group, Inc.
The Cooper Companies, Inc.
Thermo Fisher Scientific Inc.
Vitrolife Group
Western Fertility Institute

簡介目錄

Product Code: 506

Assisted Reproductive Technology Market size is expected to record a 6.9% CAGR between 2024 and 2032, driven by rising infertility rates influenced by lifestyle factors, such as stress, age, and environmental changes. Technologies, including in vitro fertilization IVF and intrauterine insemination IUI are enabling individuals and couples to overcome fertility challenges.

Assisted reproductive technology ART methods are widely developed to enhance success rates and minimize risks for patients. Moreover, the integration of new technologies and improved protocols are expanding the capabilities of ART for providing hope for individuals struggling with infertility, further reinforcing its role as a vital option in reproductive healthcare. According to a report by WHO, around 17.5% of the adult population globally is experiencing infertility. This is underscoring the critical necessity for several technologies, to expand access to affordable and high-quality fertility care.

The ART industry is segmented into type, end-user/provider, and region.

The market share from the product type segment is expected to witness substantial growth through 2032 due to a strong need for helping individuals and couples achieve their dreams of parenthood by addressing fertility challenges. ART is incorporated with advanced techniques like in vitro fertilization IVF and intracytoplasmic sperm injection ICSI for offering more personalized and effective solutions as well as integrating genetic screening and innovative treatments. As researchers are discovering new ways to enhance success rates, ART products are becoming more accessible and refined.

In terms of end-user/provider, the assisted reproductive technology market from the hospitals segment is slated to generate notable revenue during 2024-2032. This is favored by rising demand by specialists who are utilizing techniques, such as genetic screening, and cryopreservation to improve success rates and patient outcomes. Hospitals are advancing ART by integrating cutting-edge innovations like AI and gene editing to enhance diagnostic accuracy and treatment efficacy for making fertility treatments more efficient and less invasive.

Asia Pacific assisted reproductive technology industry size is likely to record a notable growth rate through 2032 driven by rising disposable incomes along with surging healthcare investments for enhancing the quality and accessibility of these services. Governments and private sectors are pouring resources into healthcare infrastructure for ensuring state-of-the-art facilities and advanced technologies, adding to the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of infertility across population base
  - 3.2.1.2 Demographical shift towards acceptance of assisted reproductive technology (ART)
  - 3.2.1.3 Technological advancements in assisted reproductive technology
  - 3.2.1.4 Rising awareness regarding assisted reproductive technology
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of procedures
  - 3.2.2.2 Social barriers and lack of advanced infrastructure in emerging countries
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Pricing analysis, 2021 - 2032
- 3.6.1 Procedure pricing analysis, by region
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Product
- 5.2.1 Media
- 5.2.2 Catheters
- 5.2.3 Needles
- 5.2.4 Vitrification devices
- 5.2.5 Incubators
- 5.2.6 Other products
5.3 Procedure
- 5.3.1 By type
  - 5.3.1.1 Fresh donor
  - 5.3.1.2 Fresh nondonor
  - 5.3.1.3 Frozen donor
  - 5.3.1.4 Frozen nondonor
- 5.3.2 By technology
  - 5.3.2.1 In-vitro fertilization (IVF)
    - 5.3.2.1.1 IVF with intracytoplasmic sperm injection (ICSI)
    - 5.3.2.1.2 IVF without ICSI
  - 5.3.2.2 Artificial insemination - intrauterine insemination (AI-IUI)

Chapter 6 Market Estimates and Forecast, By End-User/Provider, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospitals
6.3 Fertility clinics
6.4 Other end-users/providers

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Egypt
- 7.6.3 Rest of Middle East and Africa